有关2018年年度股东大会的通告及通函的澄清公告

兹提述广州白云山医药集团股份有限公司(「本公司」) 已刊发日期为2019年5月 10日的关于召开2018年年度股东大会的通告(「年度股东大会通告」) 及日期为2019年5月 11日其中包括(1)建议修订公司章程及(2)建议使用部分暂时閒置募集资金进行现金管理及(3)建议使用部分暂时閒置自有资金进行现金管理及(4)建议新增可以使用部分配售所得资金的主体及(5)建议授出发行股份的一般授权及(6)年度股东大会通告之通函(「年度股东大会通函」) 。

本公司谨此澄清,由于印刷错误,年度股东大会通告第6页(英文版本) 及年度股东大会通函第39页(英文版本) 内,三、年度股东大会出席对象及暂停办理H股股份过户登记手续日期应阅览为(改动的内容已加底线标示,以便参考) :

1. Holders of domestic shares(A shares) and overseas listed foreign shares(H shares) whosenames appear on the register of members of the Company after the end of the trading hourson 28 May 2019 (Tuesday)(including those holders of H shares who have submitted verifiedapplication documents for the transfer of shares on or before 28 May 2019 (Tuesday)) areentitled to attend the AGM. The register of members of the Company will be closed from 29May 2019 (Wednesday) to 28 June 2019 (Friday)(both days inclusive) during which notransfer of H shares will be effected. In order to determine who are entitled to attend theAGM, all share transfer documents of H shares together with the relevant share certificatesmust be lodged with the share registrar of the Company in Hong Kong, namely Hong KongRegistrars Limited, at Shops 1712-1716,17/F, Hopewell Centre, 183 Queen’s Road East, WanChai, Hong Kong, for share transfer registration no later than 4: 00 p.m. on 28 May 2019(Tuesday).」

年度股东大会通告及年度股东大会通函之中文版本所列载之相应内容准确无误。

除上述者外,年度股东大会通告及年度股东大会通函的其他所有资料维持不变。本澄清公告为年度股东大会通告及年度股东大会通函之补充,并应与该等文件一併阅览。